Liquid Embolic

DEVICE2 trials

Sponsors

Antia Therapeutics AG, BlackSwan Vascular, Inc.

Conditions

Arterial EmbolizationPeripheral Arterial Hemorrhage

Unknown Phase

Prospective Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions

Antia Therapeutics AGArterial Embolization

Start: 2016-10-31End: 2018-10-31Target: 65Updated: 2016-08-11

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

CompletedNCT04649255

BlackSwan Vascular, Inc.Peripheral Arterial Hemorrhage

Start: 2021-04-14End: 2022-08-17Updated: 2024-04-12